These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1182 related items for PubMed ID: 18456376

  • 1. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF, Løvoll O, Aaberge IS, Caugant DA, Høiby EA, Bakke H, Bergsaker MR.
    Vaccine; 2008 Jun 19; 26(26):3277-81. PubMed ID: 18456376
    [Abstract] [Full Text] [Related]

  • 2. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
    Ingels H, Rasmussen J, Andersen PH, Harboe ZB, Glismann S, Konradsen H, Hoffmann S, Valentiner-Branth P, Lambertsen L, Danish Pneumococcal Surveillance Collaboration Group 2009-2010.
    Vaccine; 2012 Jun 06; 30(26):3944-50. PubMed ID: 22504662
    [Abstract] [Full Text] [Related]

  • 3. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.
    Pediatr Infect Dis J; 2007 Sep 06; 26(9):771-7. PubMed ID: 17721369
    [Abstract] [Full Text] [Related]

  • 4. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.
    Vaccine; 2013 Dec 16; 31(52):6232-8. PubMed ID: 24176490
    [Abstract] [Full Text] [Related]

  • 5. Experience with pneumococcal conjugate vaccine in Norway.
    Aaberge IS.
    Expert Rev Vaccines; 2009 Feb 16; 8(2):159-65. PubMed ID: 19196196
    [Abstract] [Full Text] [Related]

  • 6. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
    Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.
    Vaccine; 2007 Jul 20; 25(29):5390-8. PubMed ID: 17583392
    [Abstract] [Full Text] [Related]

  • 7. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F, Horcajada I, Cañas AM, Alamo I, Bordes A, González A, Santana M, Lafarga B.
    Enferm Infecc Microbiol Clin; 2009 Jan 20; 27(1):14-21. PubMed ID: 19217998
    [Abstract] [Full Text] [Related]

  • 8. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT.
    Clin Infect Dis; 2005 Jul 01; 41(1):21-9. PubMed ID: 15937758
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV, Silk BJ, Howgate J, Baughman W, Strayhorn G, Sullivan K, Farley MM.
    Pediatrics; 2008 Mar 01; 121(3):562-9. PubMed ID: 18310206
    [Abstract] [Full Text] [Related]

  • 10. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
    Rückinger S, van der Linden M, Reinert RR, von Kries R, Burckhardt F, Siedler A.
    Vaccine; 2009 Jun 24; 27(31):4136-41. PubMed ID: 19406190
    [Abstract] [Full Text] [Related]

  • 11. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ, McIntosh ED, Reinert RR.
    Int J Infect Dis; 2010 Mar 24; 14(3):e197-209. PubMed ID: 19700359
    [Abstract] [Full Text] [Related]

  • 12. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
    Motlova J, Benes C, Kriz P.
    Epidemiol Infect; 2009 Apr 24; 137(4):562-9. PubMed ID: 18796171
    [Abstract] [Full Text] [Related]

  • 13. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Feb 15; 57(6):144-8. PubMed ID: 18272956
    [Abstract] [Full Text] [Related]

  • 14. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.
    Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249
    [Abstract] [Full Text] [Related]

  • 15. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS.
    Vaccine; 2006 Jul 17; 24(29-30):5690-9. PubMed ID: 16735083
    [Abstract] [Full Text] [Related]

  • 16. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
    Lehmann D, Willis J, Moore HC, Giele C, Murphy D, Keil AD, Harrison C, Bayley K, Watson M, Richmond P.
    Clin Infect Dis; 2010 Jun 01; 50(11):1477-86. PubMed ID: 20420501
    [Abstract] [Full Text] [Related]

  • 17. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010.
    Thoon KC, Chong CY, Tee NW.
    Int J Infect Dis; 2012 Mar 01; 16(3):e209-15. PubMed ID: 22281191
    [Abstract] [Full Text] [Related]

  • 18. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
    Tocheva AS, Jefferies JM, Rubery H, Bennett J, Afimeke G, Garland J, Christodoulides M, Faust SN, Clarke SC.
    Vaccine; 2011 Jun 10; 29(26):4400-4. PubMed ID: 21504773
    [Abstract] [Full Text] [Related]

  • 19. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.
    Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR.
    Clin Infect Dis; 2004 Sep 01; 39(5):641-8. PubMed ID: 15356776
    [Abstract] [Full Text] [Related]

  • 20. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Sep 16; 54(36):893-7. PubMed ID: 16163262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.